US Edition
Published • loading... • Updated
Why a Potential Anticancer Agent Is at a Standstill in the Trials: New Knowledge of Enzymes Could Improve Efficiency and Purity
Summary by Issuesfr
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Researchers at the University of Bayreuth have, for the first time, decrypted the key steps in the biosynthesis mechanism of fostriacin, a potential anticancer agent. The team led by Professor Frank Hahn has managed to produce in the laboratory all the enzymes involved in the process and to examine them individually under controlled conditions. [...]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
